Sign In
Buy TNYA
$0.731
+0.0191 (+2.68%)
At Close: Jun 18, 2026
TN-301 Demonstrates Tolerability, Potential for Once Daily Dosing, Target Engagement and Selectivity for HDAC6 in Phase 1 Clinical Trial of Healthy Participants
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentia
Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences
04:05pm, Thursday, 21'st Sep 2023
TN-301 First-in-Human Phase 1 Clinical Trial Results and Preclinical Combination Data to be Presented at Heart Failure Society of America Annual Scientific Meeting
Tenaya Therapeutics to Participate at the 21st Annual Morgan Stanley Global Healthcare Conference
04:05pm, Thursday, 31'st Aug 2023
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentia
Tenaya Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
04:05pm, Wednesday, 09'th Aug 2023
Dosing of First Patient in Phase 1b Trial of TN-201 On Track to Occur in Q3 2023 Data from Phase 1 Clinical Trial of TN-301 Accepted for Presentation at HFSA 2023 IND Application for TN-401 Anticipate
Wall Street Analysts Believe Tenaya Therapeutics, Inc. (TNYA) Could Rally 217.58%: Here's is How to Trade
11:26am, Monday, 15'th May 2023
The average of price targets set by Wall Street analysts indicates a potential upside of 217.6% in Tenaya Therapeutics, Inc. (TNYA). While the effectiveness of this highly sought-after metric is quest
3 Penny Stocks to Buy for 100% Returns
04:02pm, Sunday, 23'rd Apr 2023
Penny stocks are one of the easiest ways to make multibagger gains in the market. However, when looking at penny stocks to buy, you have to be comfortable taking the risk that comes with these specula
Why This Nasdaq Stock Caught Fire This Week
02:46pm, Thursday, 20'th Apr 2023
Two premium-laden buyouts sparked a wave of bargain hunting in biotech this week. Tenaya Therapeutics, a clinical-stage gene therapy company, was one of the industry's biggest winners.
Tenaya Therapeutics to Participate in Upcoming Investor Conferences
05:17pm, Tuesday, 07'th Feb 2023
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentia
Tenaya Therapeutics, Inc. (TNYA) Upgraded to Buy: Here's What You Should Know
01:33pm, Thursday, 26'th Jan 2023
Tenaya Therapeutics, Inc. (TNYA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
4 Penny Stocks To Buy In January According To Insiders
02:14pm, Friday, 20'th Jan 2023
Penny stocks to buy according to these insiders in January. The post 4 Penny Stocks To Buy In January According To Insiders appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt
5 Penny Stocks To Buy According To Analysts, Targets Up To 992%
01:33pm, Monday, 14'th Nov 2022
Analysts say these are penny stocks to buy. Do you agree?
SOUTH SAN FRANCISCO, Calif., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentia
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tenaya Therapeutics announced that it will present preclinical data at the European Society of Cardiology (ESC) Heart Failure 2022 conference.
Tenaya Therapeutics to Participate in Upcoming Investor Conferences
08:30am, Thursday, 24'th Mar 2022
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tenaya Therapeutics today announced participation in two upcoming investor conferences.
